Liu et al.25 measured BDNF levels after low-dose ketamine and esketamine, but the drugs were administered right before surgery for breast cancer, and patients had only mild to moderate depression, not necessarily treatment-resistant depression. Here, BDNF is linked to depressive symptom measurement.